SCHEMBL2811977

SCHEMBL2811977

Clc1cncc(Cl)c1N1CCN(c2nc3c4c(n2)N(Cc2ccccc2)CCC4NN3)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.36
CCNC P24863 2/20 0.33
CDK8 P49336 2/20 0.33
ADRB2 P07550 1/20 0.33
CASP1 P29466 1/20 0.32
CASP5 P51878 1/20 0.32
GAA P10253 1/20 0.32
LMNA P02545 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
KDM4E B2RXH2 1/20 0.32
CHRM4 P08173 1/20 0.31
CYP3A4 P08684 1/20 0.31
CETP P11597 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.31
TSHR P16473 1/20 0.31
HTT P42858 1/20 0.31
NAMPT P43490 1/20 0.30
HRH3 Q9Y5N1 1/20 0.30
DRD2 P14416 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2812365 0.86 DRD4 (0.39) CASP1CASP5GAAKDM4ECETP
SCHEMBL2809502 0.85 HTR6 (0.41) KDM4EHTTDRD2
SCHEMBL2809650 0.85 ALDH1A1 (0.40) LMNAKDM4ECHRM4MAPTTSHR
SCHEMBL2812041 0.85 CASP1 (0.40) CASP1CASP5GAANPSR1KDM4E
SCHEMBL537792 0.84 SIGMAR1 (0.46) CASP1CASP5GAAKDM4EMAPT
SCHEMBL2810802 0.84 CASP1 (0.43) CASP1CASP5GAALMNANPSR1
SCHEMBL2808374 0.83 CASP1 (0.47) CASP1CASP5LMNANPSR1KDM4E
SCHEMBL2809837 0.83 DRD4 (0.39) CASP1CASP5GAALMNAKDM4E
SCHEMBL2814048 0.82 TSHR (0.48) LMNANPSR1KDM4EMAPTTSHR
SCHEMBL2809611 0.82 EHMT2 (0.42) LMNAKDM4ETP53MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 HCAR2 2664/4885CCNC 31/4885CDK8 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.